Merit Medical Systems (MMSI) Depreciation & Amortization (CF) (2010 - 2026)

Merit Medical Systems' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $30.5 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 4.1% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $124.4 million (up 14.73% YoY), while the FY2025 annual figure was $123.2 million, up 19.92% from the prior year.
• Depreciation & Amortization (CF) came in at $30.5 million for Q1 2026 at Merit Medical Systems, down from $31.5 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $31.5 million in Q4 2025 to a low of $20.4 million in Q3 2022.
• A 5-year average of $25.2 million and a median of $24.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) slipped 4.36% in 2022 and increased 28.77% in 2025, its largest moves.
• Merit Medical Systems' Depreciation & Amortization (CF) stood at $20.5 million in 2022, then advanced by 15.29% to $23.6 million in 2023, then advanced by 21.12% to $28.6 million in 2024, then increased by 10.21% to $31.5 million in 2025, then retreated by 3.29% to $30.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $30.5 million, $31.5 million, and $31.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison